oligometastases

You have access
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
CARSTEN NIEDER, ASTRID DALHAUG and BÅRD MANNSÅKER

In Vivo March 2022, 36 (2) 801-805; DOI: https://doi.org/10.21873/invivo.12766
You have access
Intensity-modulated Radiation Therapy for Lymph Node Oligo-recurrence
AKIKO SATO, MOTOKO OMURA, YUMIKO MINAGAWA, KENGO MATSUI, RYOSUKE SHIRATA, HIDEYUKI HONGO, HARUMITSU HASHIMOTO, TOSHIHIRO MISUMI, TOMIO INOUE and MASAHARU HATA

In Vivo September 2020, 34 (5) 2587-2593; DOI: https://doi.org/10.21873/invivo.12076
You have access
Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases
YUKI MUKAI, IZUMI KOIKE, TATSUYA MATSUNAGA, NAHO RUIZ YOKOTA, SYOKO TAKANO, MADOKA SUGIURA, MIZUKI SATO, ETSUKO MIYAGI and MASAHARU HATA

In Vivo September 2019, 33 (5) 1677-1684; DOI: https://doi.org/10.21873/invivo.11655
You have access
Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic Prostate Cancer
CARSTEN NIEDER, ASTRID DALHAUG and ADAM PAWINSKI

In Vivo March 2019, 33 (2) 465-468; DOI: https://doi.org/10.21873/invivo.11495
You have access
Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement
CARSTEN NIEDER, ASTRID DALHAUG and ADAM PAWINSKI

In Vivo January 2019, 33 (1) 229-232; DOI: https://doi.org/10.21873/invivo.11464

Main menu